April 6, 2025 - 18:46

Tariffs will be at the center of the market action in the week ahead as Trump's latest announcements have sent stocks reeling. The past week marked the worst performance for the stock market since 2020, with investors reacting sharply to the potential implications of new tariffs on international trade. Analysts suggest that heightened trade tensions could lead to increased costs for consumers and businesses alike, further complicating an already fragile economic recovery.
As traders brace for the upcoming week, many are closely monitoring developments related to tariff policies. The uncertainty surrounding these measures has led to increased volatility, prompting investors to reassess their strategies. Major indices have experienced significant fluctuations, raising concerns about the long-term impact on growth and stability.
Market experts warn that if tariffs escalate, sectors heavily reliant on imports could face significant challenges. Consequently, investors are advised to stay informed and consider the potential ramifications on their portfolios as the situation unfolds.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...